- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
T
TNGX
Tango Therapeutics Inc
12.20
-0.15-1.21%After Hours: 12.42 +0.22 +1.80%18:47 02/20 EST
OPEN/PREV CLOSE12.23/12.35
TODAY RANGE12.03-12.75
VOL1.65M
MARKET CAP1.64B
52 WEEK RANGE1.030-13.48
AVG VOL (3M)2.83M
% TURNOVER1.22%
TURNOVER--
P/E (TTM)-13.2493
% RANGE5.83%
EPS(TTM)-0.9208
P/E(FORWARD)-13.9429
P/B8.51
BVPS1.434
DIVIDEND--
P/S31.24
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.61B
SHARES OUTSTANDING134.59M
NEXT EARNINGS02/25-03/02
FREE FLOAT132.36M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·4d ago
Most shorted stocks with up to $2B market cap as of mid-February
Seeking Alpha·5d ago
Most and least shorted healthcare stocks with up to $2B market cap
Seeking Alpha·02/11 15:00
Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff
Benzinga·02/06 20:01
Expert Outlook: Tango Therapeutics Through The Eyes Of 4 Analysts
Dow Jones·02/06 14:55
Tango Therapeutics Is Maintained at Buy by Guggenheim
Dow Jones·02/06 14:55
Tango Therapeutics Price Target Raised to $18.00/Share From $12.00 by Guggenheim
Benzinga·02/06 14:45
Guggenheim Maintains Buy on Tango Therapeutics, Raises Price Target to $18
TipRanks·02/06 12:47
Guggenheim Keeps Their Buy Rating on Tango Therapeutics (TNGX)
Reuters·02/05 01:12
Tango Therapeutics CFO Daniella Beckman Reports Disposal of Common Shares
Reuters·02/03 12:00
Tango Therapeutics CEO to Join Guggenheim Emerging Outlook Biotech Summit
Dow Jones·01/16 16:33
Tango Therapeutics Is Maintained at Overweight by Piper Sandler
Same Industry
Name/Symbol
Change%
Price